Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Molitch

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
Pituitary|June 1, 2014
We stand upon the shoulders of giants!Mark E Molitch
Clinical Endocrinology|June 17, 2010
Prolactinomas and pregnancyMark E Molitch
Pituitary|January 18, 2006
Pharmacologic resistance in prolactinoma patientsMark E Molitch
The Journal of Clinical Endocrinology and Metabolism|December 6, 2008
The cabergoline-resistant prolactinoma patient: new challengesMark E Molitch
Best Practice & Research. Clinical Endocrinology & Metabolism|December 1, 2009
Pituitary tumours: pituitary incidentalomasMark E Molitch
Journal of Neuro-Oncology|October 23, 2013
Management of medically refractory prolactinomaMark E Molitch
The American Journal of Managed Care|July 13, 2013
Current state of type 2 diabetes managementMark E Molitch
Endocrinology and Metabolism Clinics of North America|January 30, 2008
Nonfunctioning pituitary tumors and pituitary incidentalomasMark E Molitch
The Journal of Clinical Endocrinology and Metabolism|February 12, 2002
Diagnosis of GH deficiency in adults--how good do the criteria need to be?Mark E Molitch
The New England Journal of Medicine|March 7, 2014
Mutant prolactin receptor and familial hyperprolactinemiaMark E Molitch
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
Pituitary|June 1, 2014
We stand upon the shoulders of giants!Mark E Molitch
Clinical Endocrinology|June 17, 2010
Prolactinomas and pregnancyMark E Molitch
Pituitary|January 18, 2006
Pharmacologic resistance in prolactinoma patientsMark E Molitch
The Journal of Clinical Endocrinology and Metabolism|December 6, 2008
The cabergoline-resistant prolactinoma patient: new challengesMark E Molitch
Best Practice & Research. Clinical Endocrinology & Metabolism|December 1, 2009
Pituitary tumours: pituitary incidentalomasMark E Molitch
Journal of Neuro-Oncology|October 23, 2013
Management of medically refractory prolactinomaMark E Molitch
The American Journal of Managed Care|July 13, 2013
Current state of type 2 diabetes managementMark E Molitch
Endocrinology and Metabolism Clinics of North America|January 30, 2008
Nonfunctioning pituitary tumors and pituitary incidentalomasMark E Molitch
The Journal of Clinical Endocrinology and Metabolism|February 12, 2002
Diagnosis of GH deficiency in adults--how good do the criteria need to be?Mark E Molitch
The New England Journal of Medicine|March 7, 2014
Mutant prolactin receptor and familial hyperprolactinemiaMark E Molitch
Pageof 18